<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04430075</url>
  </required_header>
  <id_info>
    <org_study_id>2018-08</org_study_id>
    <nct_id>NCT04430075</nct_id>
  </id_info>
  <brief_title>MiCLASP Post Market Clinical Follow-Up (PMCF) Study</brief_title>
  <acronym>MiCLASP</acronym>
  <official_title>Transcatheter Repair of Mitral Regurgitation With Edwards PASCAL Transcatheter Valve Repair System: A European Prospective, Multicenter Post Market Clinical Follow-Up (PMCF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Edwards Lifesciences</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Edwards Lifesciences</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a postmarket clinical follow up study on the safety and effectiveness of the Edwards
      PASCAL Transcatheter Valve Repair System in transcatheter mitral valve repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objectives of this clinical study are to collect data on the safety of the Edwards PASCAL
      Transcatheter Valve Repair System in transcatheter mitral valve repair and on the
      effectiveness of the Edwards PASCAL System in improving MR and improving functional status
      and quality of life in a post market setting.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 23, 2019</start_date>
  <completion_date type="Anticipated">December 2026</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with major adverse events (MAE rates)</measure>
    <time_frame>30 days</time_frame>
    <description>The primary safety endpoint is the proportion of patients with major adverse events (MAEs) at 30 days</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in mitral regurgitation severity (scale of 0-4+) by echocardiography</measure>
    <time_frame>Discharge: defined as discharge or 7 days post-procedure, whichever comes first</time_frame>
    <description>Mitral regurgitation severity will be assessed by echocardiography at timepoint discharge on a scale from 0-4+ and compared to timepoint baseline Mitral regurgitation severity</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Mitral Regurgitation</condition>
  <condition>Mitral Insufficiency</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Edwards PASCAL Transcatheter Valve Repair System</intervention_name>
    <description>Transcatheter Valve Repair with Edwards PASCAL System</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients at or over the age of 18 determined to require percutaneous reconstruction of an
        insufficient mitral valve (MR ≥ 2+) by a Heart Team who assesses patient risk and anatomic
        suitability should be considered for inclusion in this trial.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age greater than or equal to 18 years

          -  Patient is determined to require percutaneous reconstruction of an insufficient mitral
             valve (MR greater than or equal to 2+ ) by a Heart Team who assesses patient risk and
             anatomic suitability.

          -  Patient is eligible to receive the PASCAL device per the current approved indications
             for use.

          -  Minimum 6 minutes walk test of 150m. This criteria applies only to patients presenting
             with primarily functional mitral valve regurgitation.

          -  Patient is willing and able to attend all follow up visits and to perform all tests.

        Exclusion Criteria:

          -  Patient in whom a transesophageal echocardiography is contraindicated or screening
             transesophageal echocardiography is unsuccessful

          -  Leaflet anatomy which may preclude PASCAL device implantation, proper device
             positioning on the leaflets, or sufficient reduction in mitral regurgitation

          -  Echocardiographic evidence of intracardiac mass, thrombus, or vegetation

          -  LVEDD &gt; 8.0 cm determined by transthoracic echocardiography within 60 days prior to
             submission

          -  Contraindication to transseptal catheterization

          -  Presence of an occluded or thrombosed Inferior vena cava filter that would interfere
             with the delivery catheter, or ipsilateral deep vein thrombosis is present.

          -  Mitral valve area (MVA) &lt; 4.0 cm² as measured by planimetry (If MVA by planimetry is
             not measurable, PHT measurement is acceptable)

          -  Concurrent medical condition with a life expectancy of less than 12 months in the
             judgment of the Investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philipp Lurz, Prof.Dr.med.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Centre of the University Leipzig</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>TMTT Clinical Affairs</last_name>
    <phone>+1 (949) 250</phone>
    <phone_ext>2500</phone_ext>
    <email>TMTT_Clinical@edwards.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medizinische Universität Wien/AKH Wien</name>
      <address>
        <city>Wien</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Hengstenberg, Prof. Dr.</last_name>
      <phone>+43-(0)1-40400</phone>
      <phone_ext>46140</phone_ext>
      <email>christian.hengstenberg@meduniwien.ac.at</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Klinik I- Campus Grosshadern</name>
      <address>
        <city>München</city>
        <state>Bavaria</state>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Hausleiter, Prof. Dr.</last_name>
      <phone>+49 894400</phone>
      <phone_ext>72361</phone_ext>
      <email>joerg.hausleiter@med.uni-muenchen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Immanuel Klinikum Bernau</name>
      <address>
        <city>Bernau</city>
        <state>Brandenburg</state>
        <zip>16321</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Butter, Prof. Dr.</last_name>
      <phone>+49 03338 694</phone>
      <phone_ext>610</phone_ext>
      <email>c.butter@immanuel.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Giessen UKGM</name>
      <address>
        <city>Gießen</city>
        <state>Hessen</state>
        <zip>35392</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Holger Nef, Prof. Dr.</last_name>
      <email>Holger.Nef@innere.med.uni-giessen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaeres Herzzentrum Goettingen</name>
      <address>
        <city>Göttingen</city>
        <state>Lower Saxony</state>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim Seidler, Prof. Dr.</last_name>
      <phone>+49 551</phone>
      <phone_ext>3963907</phone_ext>
      <email>tim.seidler@med.uni-goettingen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Contilia Herz- und Gefäßzentrum,Elisabeth-Krankenhaus Essen</name>
      <address>
        <city>Essen</city>
        <state>Nordrhine Westfalia</state>
        <zip>45138</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Schmitz, Dr.</last_name>
      <email>t.schmitz@contilia.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Bonn</name>
      <address>
        <city>Bonn</city>
        <state>North Rhine-Westphalia</state>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Nickenig, Prof. Dr.</last_name>
      <phone>+49 228287</phone>
      <phone_ext>15259</phone_ext>
      <email>georg.nickenig@ukb.uni-bonn.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>St.-Johannes-Hospital</name>
      <address>
        <city>Dortmund</city>
        <state>North Rhine-Westphalia</state>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helge Moellmann, Prof. Dr.</last_name>
      <phone>+49 (0231) 18 43</phone>
      <phone_ext>35 111</phone_ext>
      <email>helge.moellmann@joho-dortmund.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsmedizin der Johannes Gutenberg Universität Mainz</name>
      <address>
        <city>Mainz</city>
        <state>North Rhine-Westphalia</state>
        <zip>55313</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Von Bardeleben, Dr. med.</last_name>
      <phone>+49 6131</phone>
      <phone_ext>172892</phone_ext>
      <email>stephan.von_Bardeleben@unimedizin-mainz.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herzzentrum Universitätsklinik Dresden</name>
      <address>
        <city>Dresden</city>
        <state>Saxonia</state>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Linke, Prof. Dr.</last_name>
      <phone>+49 351450</phone>
      <phone_ext>1710</phone_ext>
      <email>axel.linke@herzzentrum-dresden.con</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitäres Herzzentrum Lübeck, Universitätsklinikum Schleswig-Holstein</name>
      <address>
        <city>Lübeck</city>
        <state>Schleswig-Holstein</state>
        <zip>23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingo Eitel, Prof. Dr.</last_name>
      <email>ingo.eitel@uksh.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum NRW - Bad Oeynhausen</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>32545</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Volker Rudolph, Prof.</last_name>
      <phone>+49 5731</phone>
      <phone_ext>1973 337</phone_ext>
      <email>vrudolph@hdz-nrw.de</email>
    </contact>
    <investigator>
      <last_name>Volker Rudolph, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kath. Marienkrankenhaus Hamburg gGmbH</name>
      <address>
        <city>Hamburg</city>
        <zip>22087</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Schaefer, Prof. Dr.</last_name>
      <phone>+ 49 (040) 25 46</phone>
      <phone_ext>21 02</phone_ext>
      <email>schaefer.kardiologie@marienkrankenhaus.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Heart Centre of the University Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philipp Lurz, Prof.</last_name>
      <phone>+49 341 865</phone>
      <phone_ext>1428</phone_ext>
      <email>philipp.lurz@medizin.uni-leipzig.de</email>
    </contact>
    <investigator>
      <last_name>Philipp Lurz, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS Ospedale San Raffaele</name>
      <address>
        <city>Milano</city>
        <state>Lombardy</state>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paolo Denti, Dr. med.</last_name>
      <phone>+0039 02 2643/5316</phone>
      <phone_ext>7102</phone_ext>
      <email>denti.paolo@hsr.it</email>
    </contact>
    <investigator>
      <last_name>Matteo Montorfano, Dr. med.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Germany</country>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>December 19, 2019</study_first_submitted>
  <study_first_submitted_qc>June 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 12, 2020</study_first_posted>
  <last_update_submitted>June 11, 2020</last_update_submitted>
  <last_update_submitted_qc>June 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

